Manufacturers/Teva Women's Health, Inc.

Teva Women's Health, Inc.

3 drugs in NADAC|0 Generic,3 Brand

Teva Women's Health, Inc. lists 3 NDCs in the CMS NADAC file (0 generic, 3 brand), at an average NADAC of $36.17 per unit, with a week-over-week move of -0.4% across products that moved. The firm's full portfolio, pricing trend are listed below.

Total Drugs

3

0G / 3B

Avg Price / Unit

$36.1691

$24.09 – $48.21

Avg 7d Change

-0.40%

Across 1 drugs with changes

7d Activity

12 flat

of 3 total drugs

Portfolio Price Trend

Monthly average NADAC price across all drugs

Frequently Asked Questions

How many drugs does Teva Women's Health, Inc. make?

Teva Women's Health, Inc. lists 3 NDCs in the CMS NADAC file — 0 generic and 3 brand products.

What is the average price of Teva Women's Health, Inc. drugs?

The average NADAC across Teva Women's Health, Inc.'s portfolio is $36.1691 per unit, ranging from $24.0884 to $48.2096.

What types of drugs does Teva Women's Health, Inc. make?

Teva Women's Health, Inc. makes drugs across 1 FDA pharmacologic class. The most common by NDC count are Folate Analog Metabolic Inhibitor (3).

Has Teva Women's Health, Inc. had any drug recalls?

No FDA enforcement recalls are matched to Teva Women's Health, Inc. in the openFDA feed.

How has Teva Women's Health, Inc.'s pricing changed recently?

Over the past 7 days, 0 Teva Women's Health, Inc. products rose and 1 fell, with a portfolio-wide average change of -0.4%.

Drug Portfolio

3 drugs total, 3 shown

Drug Price 7d Change
TREXALL 10 MG TABLET
Methotrexate
$48.2096
per EA
-0.40%
TREXALL 7.5 MG TABLET
Methotrexate
$36.2091
per EA
TREXALL 5 MG TABLET
Methotrexate
$24.0884
per EA